Dewitte A, Et Al. Blood Platelets and Sepsis Pathophysiology: A New Therapeutic Prospect in Critical Ill Patients? Ann Intensive Care. 2017 115

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 3

Dewitte A, et al. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients?

Ann Intensive Care. 2017;115.


Multiple Causes of Thrombocytopenia in
Sepsis
• Decreased platelet production in bone marrow
• Result from pre-existing conditions / from the inhibitory effect of pathogen
toxins, drugs, or inflammatory mediators
• Reduction in platelet half-life and their consumption/destruction
(peripheral mechanism)
• Linked to many events of platelet activation in sepsis, intravascular
coagulopathy, and immune mechanisms
• Drug-induced thrombocytopenia, hemophagocytosis, bleeding, and
hemodilution

Dewitte A, et al. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients? Ann Intensive Care. 2017;115.
Step-by-step of Thrombocytopenia in Sepsis
• 1st point of view:
• Platelet count reduction caused by consumption mechanisms of pathogen,
pathogen product-mediated activation, induction of apoptosis, lysis and
increased phagocytic clearance  leads to thrombocytopenia
• Following mechanisms:
• Coagulopathy, DIC, platelet sequestration by leukocytes and by inflammatory
vascular beds  stressed mechanisms of thrombocytopenia

Dewitte A, et al. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients? Ann Intensive Care. 2017;115.

You might also like